Last time company raised cash price, was driven from 4 to 20 cents to raise at 17 cents.
None of that trading apparently in the moment.
Quite to the contrary,, whilst company extended staff domestically as well as in US, added to pipeline, broadened IP listing of patents, price was capped and held low for period of negotiations.
Ever since we presented in the US our stock price was controlled and brought down methodically to create entry
price for partner.
The willingness of management to enlarge staff and pipeline regardless of financial restrictions
points to knowledge not shared with market. Rohan though amply hinted at such in his recent presentation.
FDA approval will open the doors to several meaningful developments,
all IMO
Last time company raised cash price, was driven from 4 to 20...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.8¢ | 10.3¢ | $174.9K | 1.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 1219974 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 404496 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |